ARGX-119
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for ARGX-119, covering 2024-08-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1b Study to Investigate Safety and Tolerability of ARGX-119 in Adult Participants With DOK7-Congenital Myasthenic Syndromes (CMS) [Phase 1]